Munib treats you in person, monitors your progress, and adjusts your protocol based on your individual response
They cannot verify product identity, control expectations, distinguish coincidence from causation or quantify adverse-event frequency
Supplied as a lyophilized powder, this material supports precise handling and controlled experimental conditions
These included CT-996, a once-daily oral small-molecule oral GLP-1 receptor agonist, in Phase I, for treating obesity in patients with and without Type 2 diabetes, as well as two injectable clinical drug candidates: CT-388, a once-weekly subcutaneous injectable in Phase II, for treating obesity in patients with and without Type 2 diabetes, and CT-868, a once-daily subcutaneous injectable, in Phase II, for treating Type 1 diabetes patients with overweight or obesity
What metabolic improvements can you expect with retatrutide
Investigations have focused on its receptor selectivity, hormonal regulation, and applications in controlled endocrine research models